Related Experiment Video
Updated: May 9, 2026
07:40
Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin via PINK1/Parkin Pathway-Mediated Mitophagy
Published on: May 26, 2023
Mitophagy is required for acute cardioprotection by simvastatin
Allen M Andres1, Genaro Hernandez, Pamela Lee
1Donald P. Shiley BioScience Center, San Diego State University , San Diego, California.
Antioxidants & Redox Signaling
|August 2, 2013
Summary
Simvastatin triggers Parkin-dependent mitophagy for cardioprotection, but coenzyme Q10 (CoQ) interferes with this process and statin benefits. This suggests CoQ may negate the anti-ischemic effects of statins.
Area of Science:
- Cardiovascular Research
- Cellular Biology
- Pharmacology
Background:
- Statin medications are known for their cardioprotective effects.
- Autophagy and mitophagy are crucial for preconditioning, but their role in statin-mediated cardioprotection remains unclear.
Purpose of the Study:
- To elucidate the mechanism of statin-mediated cardioprotection, focusing on the roles of autophagy and mitophagy.
- To investigate the specific involvement of Parkin-dependent mitophagy and the influence of coenzyme Q10 (CoQ).
Main Methods:
- Utilized HL-1 cardiomyocytes and mice models subjected to ischemia/reperfusion.
- Investigated the effects of simvastatin on Akt/mTOR signaling, autophagy, and mitophagy.
- Examined infarct size in Parkin knockout mice and the impact of CoQ supplementation.
Main Results:
- Simvastatin suppressed Akt/mTOR signaling and induced autophagy and mitophagy in cardiomyocytes and mouse hearts.
- Simvastatin's cardioprotective effect was dependent on Parkin, as it was abolished in Parkin knockout mice.
- Coenzyme Q10 (CoQ) supplementation blocked mitophagy and abolished simvastatin-mediated cardioprotection in vivo.
Conclusions:
- Acute simvastatin treatment activates Parkin-dependent mitophagy, which is essential for its cardioprotective effects.
- Coadministration of CoQ with simvastatin impairs mitophagy and negates cardioprotection.
- CoQ may interfere with the anti-ischemic benefits of statins mediated by mitophagy.
Related Concept Videos
01:27Autophagy
Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
01:19Translocation of Proteins into the Mitochondria
Mitochondrial precursors are translocated to the internal subcompartments via independent mechanisms involving distinct protein machineries called translocases.
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
01:18Autophagic Cell Death
Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...
01:22Cellular Injury V: Apoptosis and Autophagy
Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...
01:36Delivery Pathways to the Lysosome
Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
01:29Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...